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Cytoskeletal protein actin and nonactin cellular proteins were essential for human respiratory syncytial virus (RSV) gene
expression. In vitro, specific antibodies against actin inhibited RSV transcription, whereas antibodies against other cytoskel-
etal proteins had little or no effect. Affinity purified cellular actin or bacterially expressed recombinant actin activated RSV
transcription. However, optimal transcription required additional cellular protein(s) that appeared to function as accessory
factor(s) for actin. In the absence of actin, these proteins did not activate viral transcription. Purified viral nucleocapsids
contained actin, but no cytokeratin, tubulin, or vimentin. Cytochalasin D or DNaseI—agents that destabilize actin polymers—
had little effect on RSV transcription. RSV infection itself seemed to alter the structure of the cellular actin filaments.
Treatment of infected cells with cytochalasin D produced a more severe disruption of the filaments and drastically reduced
the production of infectious virus particles but still had little effect on intracellular synthesis of viral macromolecules. Thus
actin seems to serve a dual role in RSV life cycle: its monomeric form as well as polymeric form activate viral transcription,
while only the microfilament form may take part in viral morphogenesis and/or budding. © 1998 Academic Press
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INTRODUCTION
Human respiratory syncytial virus (RSV) is a major
pathogen of the lower respiratory tract of young infants
(Cate, 1998). RSV belongs to the Pneumovirus genus
within the Paramyxoviridae family. Like other members of
this family, RSV has a nonsegmented, negative-strand
genome RNA. The RSV genes are arranged on the
15,222-kb genomic RNA in the following order: 39-(lead-
er)-NS1-NS2-N-P-M-SH-G-F-22k-L-(trailer)-59 (reviewed
by Collins, 1991). The RSV nucleocapsid core consists of
the viral genomic RNA wrapped with N protein (called
‘‘N-RNA template’’), the phosphoprotein P and the major
subunit of the RNA-dependent RNA polymerase L. Pre-
vious studies (Barik, 1992; Huang et al., 1993) have
shown that this nucleocapsid core alone is not transcrip-
tionally active and requires cellular factor(s) for transcrip-
tion. Evidence indicating that at least one of these factors
is the cytoskeletal protein actin emerged exclusively
from in vitro studies. First, an anti-actin antibody inhibited
RSV transcription reactions in vitro (Huang et al., 1993).
Second, pretreatment of cell extract with anti-actin anti-
body destroyed its transcription stimulatory activity (Ma-
zumder and Barik, 1994). However, no detailed study has
been done to characterize the exact identity of the cel-
lular factor(s) and the nature of their interactions with the
virus. It also remained unknown whether cellular pro-
teins other than actin play a role in RSV transcription. We
have, therefore, undertaken a detailed study to charac-
terize the cellular proteins involved in RSV gene expres-
sion. In this communication, we present in vitro and in
vivo evidence for an essential role of actin and possibly
nonactin proteins in RSV transcription and morphogen-
esis.
RESULTS
Requirement of actin in RSV transcription in vitro
To identify the cellular factor(s) required for RSV tran-
scription, we first fractionated extracts of HEp-2 cells on
a Sephadex G200 column. The fractions were tested for
their actin content and ability to activate a cell-extract-
dependent RSV transcription reaction using viral nucleo-
capsids that contained N-RNA template, L, P, and 22K
proteins (Barik, 1992; data not shown). Results presented
in Fig. 1 (A and B) reveal the actin content of the frac-
tions, showing a major peak of the 43-kDa actin polypep-
tide spanning fractions 18–22. When tested in RSV tran-
scription, the stimulatory activities of these fractions es-
sentially followed their relative actin content (Fig. 1C),
suggesting that actin plays a major role in viral transcrip-
tion.
To purify the actin further, the S120 fraction of HEp-2
cells was subjected to anti-actin affinity chromatography
as described under Materials and Methods. Immunoblot
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analysis showed that the fraction that did not bind to the
anti-actin column (called ‘‘flow-through’’) was essentially
free of actin (Fig. 2A). In contrast, the eluted affinity-
purified fraction was nearly pure actin as determined by
SDS–PAGE followed by either staining (data not shown)
or immunoblot analysis (Fig. 2A). When tested in recon-
stituted RSV transcription reaction, the flow-through frac-
tion had very little transcriptional activity (Fig. 2B). The
affinity-purified actin, however, showed substantial tran-
scriptional activity; at its optimal concentration, its activ-
ity was ;30–40% compared to that of the original unfrac-
tionated extract. Based on these activities and the actin
concentration of the various preparations determined by
immunoblotting, we estimate that optimal RSV transcrip-
tion required ;2 ng actin/ng of N-RNA template. At
higher concentrations, the total extract showed some
inhibitory effect on transcription, presumably due to the
presence of small amounts of RNase in the extract.
To further substantiate the role of actin, specific anti-
bodies against the various cytoskeletal proteins were
added to the reconstituted RSV transcription reaction.
While the anti-actin antibody as well as an anti-RSV
antibody inhibited viral transcription (Fig. 3), antibodies
against vimentin, tubulin, cytokeratins or the nonrelevant
protein phosphatase l did not have any significant effect.
These results suggest that the nonactin cytoskeletal pro-
teins mentioned above do not play an important role in
RSV transcription. Additionally, they confirm and extend
FIG. 1. Fractionation of cell extract. S120 extract of HEp-2 cells was fractionated through Sephadex G200 gel filtration column as described
(Materials and Methods). Selected fractions were subjected to SDS–PAGE followed by staining with Coomassie blue R-250 (A) or immunoblot
detection using anti-actin antibody (B). Stimulatory activities of representative fractions were assayed in reconstituted RSV transcription reactions (C).
Fraction numbers are shown on top of the gels. The arrow points to the actin bands. Lane M represents protein standards of Mr values in thousands.
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previous findings (Huang et al., 1993; Mazumder and
Barik, 1994) and provide direct evidence that actin is a
component of the RSV transcription complex.
Role of nonactin cellular protein(s) in RSV
transcription
Since the affinity-purified actin was only partially active
in comparison to the less purified material (see Fig. 2B),
we considered the possibility that a nonactin component
may be essential for viral transcription in the presence of
actin and may have been lost during the affinity purifica-
tion. Thus increasing amounts of the nonactin fraction
(flow-through in Fig. 2A) was used to supplement various
amounts of affinity-purified actin in RSV transcription
reactions. Results in Fig. 4 show that the nonactin frac-
tion did stimulate transcription in the presence of actin
and that this effect was saturable at any given concen-
tration of actin. At the optimal concentration of both
fractions, transcription was saturable at ;2 ng actin/ng
N-RNA template, as observed earlier (Fig. 2). Together,
these results suggest that although actin plays a cardinal
role in RSV transcription, one or more nonactin cellular
proteins may serve to stimulate transcription further.
These factors cannot replace actin for transcription, and
therefore, most likely function as an accessory factor for
actin.
To gain an understanding of the nature of the acces-
sory factor(s), we tested its sensitivity to various treat-
ments. The nonactin fraction was incubated with trypsin,
micrococcal nuclease, phage lambda phosphatase, and
N-ethylmaleimide (NEM); following treatment, the agents
were neutralized with TLCK, EGTA, sodium vanadate
(Barik, 1993), and DTT, respectively. Treatment with phos-
pholipase C was also carried out in a similar manner but
without subsequent neutralization of the enzyme. In an-
other series of experiments, the protein fraction was
heated at various temperatures and then cooled in ice.
The treated proteins were then tested for their RSV tran-
scription activity in the presence of affinity purified actin.
Results in Table 1 show that the activity of the factor(s) is
FIG. 2. Transcriptional activity of affinity-purified actin. HEp-2 cell
S120 was subjected to affinity chromatography on an anti-actin column
as described (Materials and Methods). The S120 extract (total extract;
5 and 10 mg in lanes 1 and 2), unbound fraction (flow-through or FT; 5
and 10 mg in lanes 3 and 4), and eluted actin (eluate or EL; 20 and 50
ng in lanes 5 and 6) were subjected to immunoblot analysis using
anti-actin antibody (A) or tested for transcriptional activity in reconsti-
tuted RSV transcription in vitro (B).
FIG. 3. Effect of cytoskeletal antibodies on RSV transcription. Anti-
bodies against the indicated proteins were added to 20 ml of the
reconstituted transcription reaction containing total cell extract and all
the other components (Materials and Methods) except ribonucleotides,
and the mixture was incubated at 30°C for 10 min. The ribonucleotide
mixture, including g-32P-UTP, was then added, and the reaction contin-
ued for another 2 h followed by DE81 paper-binding assay (Materials
and Methods). ‘‘None’’ indicates a nonimmune rabbit antibody. The
numbers above each bar indicate the amount of antibody used (1 or 2
mg).
FIG. 4. Stimulation of RSV transcription by nonactin cell fraction. The
protein concentration of the nonactin fraction (that did not bind to
anti-actin column) was adjusted to 5 mg/ml, and 0–1 ml of it was used
in RSV transcription reactions reconstituted with the indicated amounts
of affinity purified HEp-2 cell actin (0–300 ng) as shown.
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extremely sensitive to heat and trypsin and is inhibited
by ;70% at an NEM concentration of 2 mM. The activity
was essentially resistant to micrococcal nuclease (Table
1) and phospholipase (data not shown). These results
indicate that the factor is most likely to be proteinaceous,
unphosphorylated, and devoid of any nucleic acid or lipid
component. Additionally, the NEM sensitivity points to a
role of sulfhydryl groups in its function.
Transcriptional activity of recombinant actin
To facilitate studies of the role of actin in RSV tran-
scription, we decided to test the activity of bacterially
synthesized actin in transcription in vitro. The bacterial
expression clone, which has been described earlier
(Gao et al., 1992), was shown to produce insoluble actin,
perhaps as inclusion bodies. The insoluble actin was,
therefore, dissolved in 6 M guanidinium chloride and
partially purified by gel filtration chromatography as de-
scribed under Materials and Methods. When tested di-
rectly in RSV transcription in vitro, the guanidine-dena-
tured actin supported transcription (Table 2). However,
when the actin was diluted in the transcription buffer
beforehand, it precipitated once again as observed ear-
lier (Gao et al., 1992) and did not support transcription.
We believe that the actin must have a strong affinity for
some of the viral macromolecules present in the tran-
scription reaction, which acted essentially as chaper-
ones and helped the actin to renature during the dilution
of guanidine. Inhibition of this transcription by anti-actin
antibody (Table 2) suggested that the transcriptional ac-
tivity was indeed due to the recombinant actin. This was
further supported by the fact that an essentially similar
fraction obtained from BL21(DE3) containing vector pET
plasmid did not support RSV transcription (data not
shown). Optimal transcription was attained with ;150 ng
recombinant actin and 100 ng viral N-RNA template in a
20 ml reaction. At higher concentrations, the recombinant
actin preparation inhibited transcription (Table 2). This
was most likely due to its guanidine content because
equivalent amounts of guanidine by itself (;30 mM or
above) inhibited standard RSV transcription (Table 2).
Interestingly, when we added the actin-free fraction
(flow-through in Fig. 2) to transcription reactions recon-
stituted with optimal amounts of recombinant actin, tran-
scription was stimulated even further. Together, these
results demonstrate that the recombinant bacterial actin
alone exhibits a basal transcriptional activity that can be
further stimulated by the addition of nonactin eukaryotic
proteins.
RSV gene expression and the polymeric status of
actin
Since actin has a natural propensity to polymerize, the
next logical question was whether the monomeric or the
polymeric form of actin is functional in RSV transcription.
Curiously, the conditions that promote the polymerization
of actin are very similar to those that are also absolutely
required for RSV transcription reaction in vitro, viz., pres-
ence of monovalent cations, Mg21 and ATP, and incuba-
tion at near-physiological temperatures (Barik, 1992;
TABLE 2
Transcriptional Activity of Recombinant Bacterial Actin
Macromolecules
(RNP 1 the following)
Transcriptional activity
(pmoles of UMP
incorporated/mg N-RNA/h)
1. None 0.3
2. Rec. actin, 40 ng 1.1
3. Rec. actin, 80 ng 1.8
4. Rec. actin, 160 ng 2.8
5. 4 1 nonactin fraction, 1 mg 3.5
6. 4 1 nonactin fraction, 2 mg 4.1
7. 4 1 nonactin fraction, 3 mg 5.0
8. 7 1 Gn-HCl, 10 mM 4.9
9. 7 1 Gn-HCl, 40 mM 3.8
10. 4 1 anti-actin, 1 mg 0.5
11. 6 1 anti-actin, 1 mg 0.6
12. 7 1 anti-actin, 1 mg 0.6
Note. Reconstituted RSV transcriptions using various amounts of
guanidine-dissolved recombinant actin (Rec. actin) and nonactin frac-
tion (unbound material from anti-actin column, as in Fig. 4) were carried
out as described under Materials and Methods.
TABLE 1
Properties of the Nonactin RSV Transcription Factor
Treatment
Transcriptional activity
(pmoles of UMP
incorporated/mg N-RNA/h)
None 6.2
65°C, 5 min 1.4
95°C, 5 min 0.4
DNaseI, 5 units, 5 min 5.6
DNaseI, 10 units, 10 min 5.5
Cytochalasin-D, 4 mg/ml 5.9
Cytochalasin-D, 8 mg/ml 5.7
Trypsin, 100 ng 0.5
Trypsin inhibitor 5.9
Micrococcal nuclease, 50 ng 5.0
Lambda phosphatase, 50 ng 5.8
N-ethylmaleimide 0.8
Note. Reconstituted RSV transcriptions using affinity purified actin
(200 ng) and the pre-treated nonactin fraction (unbound material from
anti-actin column) were carried out as described under Materials and
Methods. In the case of DNaseI and Cytochalasin-D, both the affinity
purified actin and the nonactin fractions were pretreated, and the same
concentrations were also maintained throughout the transcription re-
action as well. Although the micrococcal nuclease action was termi-
nated by chelating the Ca21 with EGTA, it is possible that small
amounts of the nuclease may have escaped inhibition and degraded
some RSV transcripts. Values are an average of two to three reactions
with a ,10% deviation.
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Huang et al., 1993). Thus it was not possible to eliminate
any of these conditions to test whether the polymeric
nature of actin is essential for RSV transcription. We
have, therefore, employed chemicals that specifically
destabilize actin filaments and tested their effects on
RSV transcription in vitro. These included DNaseI and
cytochalasin D (CD), both of which form complexes with
actin and either prevent the formation of new polymers or
induce depolymerization of existing ones (recently re-
viewed by Furukawa and Fechheimer, 1997). As shown in
Table 1, neither of these compounds inhibited RSV tran-
scription in vitro, suggesting that at least in vitro, RSV
transcription does not require highly polymeric actin.
To investigate whether the filamentous or soluble form
of actin is important for RSV gene expression in infected
cells, we studied RSV growth and macromolecular syn-
thesis in CD-treated HEp-2 cells using a number of
techniques. First, immunofluorescence analyses were
carried out to monitor the effect of CD on actin and
assess RSV protein synthesis, using anti-actin and anti-
RSV antibodies, respectively. Representative immunoflu-
orescence results, collated in Fig. 5, show that 7.5 mg/ml
CD significantly disrupted the microfilament network as
well as the normal cellular morphology (compare Figs.
5A and 5B). Whereas the actin in untreated cells ap-
peared as filaments, that in the CD-treated cells ap-
peared in clumps, which is characteristic of such treat-
ments (Cooper, 1987). Yet treatment of RSV-infected cells
with 7.5 mg/ml CD had no discernible effect on the
expression of viral proteins, detected as punctate spots
in the infected cells (Figs. 5C and 5D), suggesting that
RSV gene expression continued in cells in which actin
filaments were substantially destroyed. Next, immuno-
blot analysis of cell extracts was performed to estimate
FIG. 5. Lack of effect of CD on RSV protein synthesis ex vivo. RSV infection and staining of HEp-2 cells grown on coverslips were carried out as
described under Materials and Methods. (A) Uninfected cells; 0 mg/ml CD; FITC-phalloidin stain. (B) Uninfected cells; 7.5 mg/ml CD; FITC-phalloidin
stain. (C) RSV-infected cells; 0 mg/ml CD; anti-RSV stain. (D) RSV-infected cells; 7.5 mg/ml CD; anti-RSV stain. (E) Uninfected cells; anti-RSV stain.
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RSV P protein synthesis as a measure of RSV gene
expression. Since at the time point of this experiment (24
h p.i.) the bulk of the viral protein synthesis originates
from secondary transcription of de novo replicated ge-
nomes (reviewed by Banerjee et al., 1991), quantitation of
viral protein levels provides a measurement of essen-
tially all viral macromolecular synthesis. In parallel ex-
periments, these cells were metabolically labeled with
[35S]methionine, and total viral protein synthesis was
measured by immunoprecipitation of the cell extracts
with a specific anti-RSV antibody followed by SDS–PAGE
analysis. Results of both immunoprecipitation (Fig. 6) and
immunoblot (data not shown) analyses led to the conclu-
sion that RSV protein synthesis was unaffected by CD. In
addition, viral genomic RNA was estimated by quantita-
tive RT–PCR using primers against the 59 end of the NS1
gene and the 39 end of the NS2 gene. The same amount
of PCR product was generated starting with equal
amounts of RNA from CD-treated or untreated RSV-in-
fected cells (data not shown). Together, these results
suggested that disruption of the intracellular F-actin net-
work had little effect on the synthesis of viral macromol-
ecules.
Since cytochalasin-treated HEp-2 cells had lost their
normal elongated morphology and appeared to have
shrunk to a certain degree, it was not possible to detect
RSV-induced fusion (syncytium) in these cells. To assess
viral morphogenesis, therefore, we measured viral titer
from these cells at 40 h p.i. Results presented in Fig. 7
show a 103- to 104-fold reduction of RSV titer in cytocha-
lasin-treated cells compared to the untreated ones. As a
control, we used nocodazole, a microtubule-disrupting
agent that had essentially no effect on RSV titer. The
effect of these drugs on another nonsegmented negative
strand virus, viz., vesicular stomatitis virus (VSV) was
tested. While treatment of the infected cells with CD had
no effect on the titer of VSV, confirming earlier results
(Gupta et al., 1998; Ravkov et al., 1998) nocodazole treat-
ment lowered VSV titer by nearly 103-fold (Fig. 7). Thus an
intact F-actin microfilament system appeared to be spe-
cifically important for the assembly or budding of RSV
virions but not for RSV gene expression per se.
Disruption of intracellular microfilament network by
RSV
In an attempt to examine the effect of RSV infection on
the F-actin network, we next compared the staining of
actin filaments in RSV-infected and uninfected cells. As
shown in Fig. 8, the microfilaments, probed with FITC-
labeled phalloidin, could be readily observed in the un-
infected HEp-2 cells. To our surprise, however, the actin
fluorescence in the RSV-infected cells appeared punc-
tate and diffused overall, suggestive of at least a partial
degradation of the actin network upon viral infection. The
infected status of these cells was ascertained by RSV-
specific immunostaining (as in Fig. 5; data not shown). In
general, however, the viral effect on actin network and
cellular morphology appeared less severe than that of
cytochalasin (compare Figs. 5 and 8).
Cytoskeletal proteins in mature RS virions
Analysis of polypeptides present in mature RS virions
has documented the presence of actin even in the purest
FIG. 7. Effect of cytoskeletal disruption on virus morphogenesis.
Titers of progeny virus (RSV, circles; VSV, squares) in the culture media
of infected cells treated with the indicated concentrations of cytocha-
lasin D (CD) or nocodazole (NZ) were determined as described under
Materials and Methods.
FIG. 6. Lack of effect of CD on the rate of RSV protein synthesis.
Metabolic labeling of RSV-infected cells with [35S](methionine plus
cysteine) at 18 h p.i., immunoprecipitation of labeled RSV proteins with
specific anti-RSV antibody, and analysis of the precipitate by SDS–
PAGE was carried out as described under Materials and Methods. An
autoradiograph of the dried gel is shown. Representative results with
two concentrations of CD are presented. Mr values of protein stan-
dards and the major RSV proteins are marked on the left and right,
respectively.
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preparations of the virus (Barik, 1992), suggesting that
the essential role of actin in RSV transcription may un-
derscore its natural affinity to bind to the viral nucleo-
capsid and thereby become packaged in the virions.
Much of this actin could be dissociated during further
purification of the nucleocapsid (data not shown), how-
ever, it showed very little activity when added back in
RSV transcription reactions in vitro (data not shown).
While the reason for this low activity is under investiga-
tion, we wanted to test whether any other major cytoskel-
etal protein is also packaged in RS virions. Purified RS
virions were therefore subjected to immunoblot analysis
using antibodies against cytokeratins, tubulin, and vi-
mentin. Results presented in Fig. 9 demonstrate that
whereas actin could be detected in the virions, the other
cytoskeletal proteins were essentially absent. As a con-
trol, all four cytoskeletal proteins could be detected in the
total extract of HEp-2 cells—the same cell line in which
the RS virions were grown. The observed mobilities of
these proteins were within the range of their published
Mr values: actin, 42 kDa; tubulin, 55 kDa; and vimentin,
58 kDa. The pan-cytokeratin antibody mixture used in our
studies detected two major species of HEp-2 cell cyto-
keratins of approximate Mr 50 and 58 kDa. Thus it seems
that among the five major cytoskeletal proteins identified
in the epithelial cells, actin is the only one that is pack-
aged within the mature RS virions. These results are in
agreement with a specific affinity of the viral nucleocap-
sid for actin and a lack of affinity for the nonactin cy-
toskeletal proteins.
DISCUSSION
Actin filaments have long been recognized as the
primary determinants of cytoskeletal strength, cytokine-
sis, and cellular morphology (reviewed in Furukawa and
Fechheimer, 1997). It is relatively recently, however, that
other—and arguably secondary—roles of actin have
begun to be appreciated. Notable among these are its
roles in viral growth, the assembly and functioning of the
translation machinery, and even more recently, signal
transduction (reviewed in Bassell and Singer, 1997; Cud-
more et al., 1997; Hall, 1998). In this communication, we
have documented a direct participation of actin in the
gene expression of respiratory syncytial virus, a nega-
tive-strand RNA virus of the Pneumovirus genus. We
have shown that the relationship is reciprocal in that the
microfilament network was destabilized in the RSV-in-
fected cells. In addition, we have presented preliminary
evidence for the existence of an additional cellular factor,
likely an accessory protein for actin, that further stimu-
lates RSV transcription. We would like to add here that
despite our best efforts we have been unable to activate
RSV transcription with commercial preparations of actin
(Sigma, Boehringer-Mannheim). This is reminiscent of
similar frustrations with HPIV-3 and is presumably due to
a nonphysiological aggregation of commercial actin (De
et al., 1993). Nevertheless the activation of RSV transcrip-
tion by bacterial recombinant actin will now make it
possible to map, through site-directed mutational analy-
sis, the domain(s) of actin required for this function.
In the last few years, actin has been shown to play
important roles in the gene expression and maturation of
FIG. 8. Disruption of cellular microfilaments by RSV. Infection of HEp-2 cells by RSV, immunofluorescent staining for actin, and photomicrography
were carried out as described under Materials and Methods. (A) Uninfected cells, FITC-phalloidin label. (B) RSV-infected cells; 24 h p.i.; FITC-
phalloidin label.
FIG. 9. Cyskeletal proteins in RSV virion. Immunoblot showing spe-
cific presence of actin and absence of cytokeratins (cytoker.), tubulin,
and vimentin in purified RS virions (R; 60 mg protein per lane). Analyses
of total HEp-2 cell extract (H; 10 mg protein per lane) display all of the
corresponding proteins, indicated by arrows. Mr values of the standard
protein markers are shown at right.
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a number of viruses. Genetic and in vitro reconstitution
studies, mainly in VSV, human parainfluenza virus type 3
(HPIV-3), and recently in RSV have shown that the mini-
mal RNA-dependent RNA polymerase of nonsegmented
negative-strand RNA viruses consists of the large protein
L and the phosphoprotein P (reviewed by Banerjee et al.,
1991; Barik, 1992; Mazumder and Barik, 1994; Yu et al.,
1995). Together, they copy the genomic RNA wrapped
with N protein (also referred as N-RNA template) to
produce mRNAs for each gene or the genome comple-
ment. However, some of these viruses may have evolved
to use additional, specialized proteins for further regula-
tion of this basal transcription machinery. The 22K (M2
ORF1) protein of RSV, for example, has been shown to
function as a transcription elongation factor that in-
creases the processivity and readthrough of the polymer-
ase (Collins et al., 1996; Hardy and Wertz, 1998). Similarly,
the M2 (ORF2) and NS1 proteins of RSV and the C protein
of Sendai virus may function as transcription inhibitory
factors (Cadd et al., 1996 and references therein; Collins
et al., 1996; Atreya et al 1998). It is now becoming in-
creasingly apparent that the cytoskeletal proteins may
represent yet another class of transcription factor for
many viruses of this family. In vitro, transcription of Sen-
dai, measles and VSV was shown to be dependent on
tubulin to various extents (Moyer et al., 1986, 1990;
Takagi et al., 1996). Ex vivo, the transcription complex of
Newcastle diseases virus (NDV) irreversibly assembled
on the cytoskeletal framework and was shown to syn-
thesize nascent viral RNA (Hamaguchi et al., 1985). For
HPIV-3, partially purified actin stimulated viral transcrip-
tion in vitro and imparted a helical structure to the viral
nucleocapsid (De et al., 1993). This led the authors to
propose that the alteration of the nucleocapsid structure
is due to the polymerization of the associated actin and
that this underlies the mechanism of transcriptional ac-
tivation. In cells infected with Black Creek Canal virus
(BCCV), a New World Hantavirus, the viral N protein but
not the glycoproteins associated with actin (Ravkov et al.,
1998). Treatment of the cells with CD prior to or during
absorption of BCCV had no effect on viral yield; however,
treatment at 3 days p.i. reduced viral yield by 94%, sug-
gesting that actin filaments may play a role in the as-
sembly and/or release of the hantavirus. Actin filaments
have also been implicated in the assembly/budding of
measles virus, vaccinia virus, and retroviruses (Bohn et
al., 1986; Cudmore et al., 1995; Rey et al., 1996). In fact, for
measles and vaccinia, budding itself appeared to be a
result of the vectorial growth and protrusion of the mi-
crofilaments through the cell membrane. As in BCCV, the
N protein of HPIV-3 colocalized with actin microfilaments
(Gupta et al., 1998). Unlike in BCCV, however, CD-treat-
ment not only resulted in a 104-fold reduction in the yield
of infectious HPIV-3 but also reduced HPIV-3 intracellular
RNP synthesis by ;60%, suggesting a functional role of
actin microfilaments in HPIV-3 replication.
Based on the foregoing, it appears that RSV has
adopted a combination of the ways in which actin is
utilized by other viruses, i.e., in gene expression as well
as in virion morphogenesis. Like HPIV-3, RSV required
actin for transcription in vitro, however, the polymeric as
well as the monomeric actin was equally effective in this
role. This conclusion is based on the finding that actin
efficiently activated RSV transcription in vitro in the pres-
ence of agents that favored polymerization, e.g., Mg21,
NaCl, and ATP (reviewed by Carlier, 1991) as well as
those that either favored a net depolymerization of the F
actin or prevented polymerization of G actin, e.g., cy-
tochalasin D and DNaseI (Table 1). Ex vivo, cytochalasin
D disrupted the microfilament network without signifi-
cantly affecting intracellular synthesis of RS viral macro-
molecules (Figs. 5 and 6).
In contrast, the maturation and/or budding of RS viri-
ons appears to depend on the filamentous form of actin
since a drastic fragmentation of the microfilaments by
CD inhibited RSV maturation (Fig. 7). As a corollary, we
presume that the RSV-mediated fragmentation of the
filaments is a more regulated process causing a less
drastic—and perhaps selective and organized—disrup-
tion of the network. It is possible that the membrane-
proximal ends of the disintegrated microfilaments still
remain tethered to the infected cell membrane and aid in
RS virion maturation or budding. Elegant electron micro-
scopic studies have recently revealed that RSV buds
through the apical surface of polarized epithelial cells
(Roberts et al., 1995). It is perhaps not a coincidence that
polymeric actin is found to be more concentrated on the
apical surface of villus epithelial cells (Cheng and
Bjerknes, 1989). Together, these findings lend further
credence to our conclusion that actin filaments are re-
quired for RSV maturation and budding.
The existing knowledge of the involvement of cytoskel-
etal proteins in negative-strand RNA virus gene expres-
sion allows us to make a few more generalizations.
While different viruses exploit different cytoskeletal pro-
teins for this purpose, for any given virus the relevant
protein appears to be packaged in the mature virions,
usually in association with the viral nucleoprotein com-
plex. These include—but are not limited to—tubulin in
VSV (Moyer et al., 1986; our unpublished observation)
and measles virus (Moyer et al., 1990) and actin in
HPIV-3 (De et al., 1993) and RSV (Barik, 1992; Fig. 9). The
absence of tubulin, vimentin, and cytokeratins in the RS
virion (Fig. 9) demonstrated that such association is
indeed specific. Thus we propose that the relatively sim-
ple detection of a specific cytoskeletal protein in the
mature virion may have a predictive value regarding the
role of the protein in the viral gene expression. This will
be particularly useful in viruses for which purified tran-
scription systems may not yet exist.
The discovery of a novel cellular transcription factor of
RSV, likely nonactin and proteinaceous in nature (Table
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1), adds a new dimension to RSV gene expression. Al-
though we do not yet know the number and identity of the
factor(s), our results clearly suggest that it is needed in
addition to actin and cannot function in the absence of
actin (Figs. 2 and 4). Our working hypothesis is that the
factor is probably an accessory to actin function and may
represent one or more actin-binding proteins in the cell.
We presume that by binding to actin, it maintains actin, or
a relevant domain thereof, in a transcriptionally compe-
tent conformation. It is important to mention here that in
a recent report, the cellular ezrin-radixin-meosin (ERM)
proteins, members of the cytoskeleton-binding proteins
of the band 4.1 superfamily, were also detected in the
virions of a number of negative-strand RNA viruses, such
as VSV, rabies, Newcastle disease, and influenza (Sa-
gara et al., 1995). It will be interesting to see whether the
ERM proteins are present in other virions as well and
whether they serve as accessory transcription factors for
the viral polymerases, e.g., as a cofactor for tubulin in
VSV or actin in RSV.
Disruption of the cytoskeletal network by RSV, as re-
ported here, is not without precedence (reviewed by
Cudmore et al., 1997). In a preliminary report, RSV infec-
tion of HEp-2 or HeLa cells was shown to cause mor-
phological alterations in the intermediate filaments (IF)
starting at ;36 h p.i., concomitant to the conversion of
cytokeratin 18 (46 kDa) to a more acidic form with a
slower mobility on SDS–PAGE (Garcia-Barreno et al.,
1988). In addition, a portion of the viral N protein was
found associated with a cellular fraction that was insol-
uble to salt and detergents and also contained IF. While
this manuscript was in preparation, Ulloa et al. (1998)
reported a net decrease in polymerized actin in RSV-
infected cells. Our results demonstrating an absence of
vimentin or cytokeratins in mature RSV (Fig. 9) and the
lack of an effect of the corresponding antibodies in RSV
transcription make it unlikely that these proteins may
have a direct role in RSV gene expression. It is evident
that the specificity and significance of the association of
RSV with the various cytoskeletal components need to
be investigated further. Earlier, infection of epithelial
cells as well as fibroblasts by Paramyxoviruses, viz.,
measles, mumps, Sendai, and NDV, was reported to
result in a striking decrease of actin microfilament that
correlated with the presence of actin in these virions
(Fagraeus et al., 1978). In a more recent study (Ceccaldi
et al., 1997), rabies infection led to a decrease in cellular
microfilament content, probably through an indirect ef-
fect of viral nucleocapsid on actin-binding proteins such
as synapsin I. Examples of other viruses that have been
shown to disrupt the microfilament network include: po-
lio (Lenk and Penman, 1979), vaccinia (Meyer et al.,
1981), rubella (Bowden et al., 1987), and mengo (Rubino
et al., 1991). For the vast majority of these viruses, it
remains undetermined whether the viral disruption of the
cytoskeleton is a directed process that serves a useful
purpose in the viral life cycle. It is tempting to speculate
that such viruses, like vaccinia, also generate protrusion
of actin filaments through the cell membrane to promote
budding of the virions and that the monomeric actin
generated from hydrolysis at the severed cytoplasmic
end of the filament may be utilized to synthesize an
extension of the polymer at the membrane end. Since
RSV is a highly cell-associated virus, a role of the new
outgrowth of actin in the cell-to-cell spread of the virus is
also a distinct possibility. Clearly, the multiple roles of
actin in the life cycle of RSV warrant further study. Addi-
tionally, studies of the destabilization of the microfila-
ments and/or other cytoskeletal structures by RSV may
unravel potentially novel pathways of signal transduction
related to RSV gene expression and pathogenesis.
MATERIALS AND METHODS
Antibodies
Monoclonal mouse antibody that reacts with all six
known actin isoforms was purchased from Boehringer-
Mannheim. Monoclonal antipan cytokeratin against cy-
tokeratin 4, 5, 6, 8, 10, 13, and 18, rabbit anti-tubulin, and
monoclonal anti-vimentin antibodies were from Sigma
(St. Louis, MO). The goat anti-RSV antibody was raised
against whole RSV and reacts with all the structural
proteins of RSV (Accurate Chemical and Scientific Corp.,
Westbury, NY). Recombinant lambda phosphatase was
purified as described (Ansai et al., 1996), and antibody
against it was raised in chicken (Lampire Biologicals,
PA); the IgY fraction was purified from the egg yolks
using a combination of ammonium sulfate precipitation
and affinity chromatography on IgSorb columns (Pro-
mega Corp., Madison, WI). All secondary antibodies,
conjugated to appropriate enzyme (horseradish peroxi-
dase for use in immunoblot) or fluorescent dye (FITC or
rhodamine) were obtained from Sigma.
SDS–PAGE and immunoblot (Western blot) analyses
were carried out essentially as described earlier (Ma-
zumder et al., 1994) except that the SuperSignal Ultra
chemiluminescence procedure (Pierce, Rockford, IL)
was used for the development of the secondary antibody.
Immunofluorescence and inhibition studies
HEp2 cells, grown to 80% confluency in monolayers on
microscope cover-slips, were infected with RSV (Long) at
m.o.i. of 2. For the experiment described in Fig. 8, the
infected monolayer at 24 h p.i. was rinsed with phos-
phate-buffered saline (PBS), and the cells were fixed with
ethanol (30 s) and acetone (2 min), both at 220°C. The
cells were then probed with a mouse anti-RSV monoclo-
nal antibody blend (Chemicon International) followed by
donkey anti-mouse IgG coupled with TRITC (kindly pro-
vided by Dr. Anthony Gard) for 30 min each in a humid
environment at room temperature. Cells were washed
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with PBS after each antibody treatment. Actin filaments
were directly stained with FITC-conjugated phalloidin
(Sigma). The coverslips were mounted with DABCO and
viewed with an Olympus BMAX Epifluorescence micro-
scope using a 3100 oil-immersion objective and appro-
priate filters.
An essentially similar infection protocol was used for
experiments involving inhibitory drugs with the following
changes. At 2–3 h p.i., the media were replaced with
fresh prewarmed media containing cytochalasin D or
nocodazole (both from Sigma) at final concentrations of
0, 2.5, 5.0, and 7.5 mg/ml. For immunostaining of RSV, the
goat anti-RSV antibody (described under Antibodies) and
the corresponding secondary antibody were used, and
the stained cells were viewed with the same microscope
and objective as above. For immunoprecipitation, the
infected cells were labeled with [S35](methionine plus
cysteine) at 18 h p.i. and processed essentially as de-
scribed earlier (Mazumder et al., 1994). For quantitation
of released infectious virions, cell-free supernatants of
the infected monolayers were harvested at 24 h p.i. (for
VSV) or at 40 h p.i. (for RSV) and titered on BHK-21 (for
VSV) or A549 cells (for RSV).
Reverse transcription and PCR (RT–PCR) were carried
out to quantitate intracellular RSV genomic RNA essen-
tially as described earlier (Mazumder et al., 1994). In
brief, equal amounts of total RNA (by A260 measurement)
isolated from infected HEp-2 (or control uninfected) cells
were reverse transcribed using Mu-MLV reverse tran-
scriptase (RT) and the (1) sense (mRNA sense) primer
59ATGGGCAGCAATTC39 corresponding to the 59 end of
the NS1 gene. This resulted in the specific synthesis of
‘‘first strand’’ cDNA complementary to the negative
stranded viral genome. The remaining RNA was then
digested with DNase-free RNase. The reaction was
heated at 95°C for 5 min to inactivate the RT. PCR was
reconstituted using extra water and dNTPs, PCR buffer,
and the other primer (59TTATGGATTGAGATC39, corre-
sponding to the 39 end of the NS2 gene). In parallel
reactions, control actin mRNA was amplified in a similar
manner using specific primers that had similar annealing
temperatures (Bitko et al., 1997). PCR was performed for
20, 25, and 30 cycles to ensure that the amplification was
below saturation for at least one of these cycle numbers
in any given set of experiments. The yield of the NS1–
NS2 genome segment was normalized against the actin
PCR product.
Reconstituted RSV transcription
Viral nucleocapsids that required cell extract for tran-
scription in vitro were prepared essentially as described
previously (Mazumder and Barik, 1994). The preparation
contained N-RNA template, L, and P proteins, as well as
small amounts of actin and the viral 22K protein. The 22K
protein was detectable only by immunoblotting using
antibodies raised against bacterially synthesized recom-
binant 22K protein (Vira Bitko and S. B., unpublished
results). Reconstitution of standard viral transcription re-
actions and measurement of incorporation of a-32P-UMP
by DE81 paper binding were carried out essentially as
described earlier (Mazumder and Barik, 1994). Addition-
ally, 5 units of RNasin (Promega Corp., Madison, WI)
were included in a 20-ml reaction. Where mentioned,
antibodies and other potential modifiers of transcription
were added to the reaction mixture at indicated times
and concentrations.
Fractionation of HEp-2 cell extract
Soluble cytosolic actin was purified as follows. HEp2
cells were grown to confluency in T-150 flasks, briefly
washed with ice-cold buffer A (10 mM Tris–HCl, pH 7.5, 5
mM b-mercaptoethanol), then harvested and resus-
pended in the same buffer (0.5 ml per T-150 flask). Unless
otherwise stated, all the following operations were car-
ried out at 0–4°C. Cells were lysed by repeated pipetting
and the extract was clarified by sonication. The lysate
was centrifuged at 120,000 g for 1 h. The supernatant
(S120) is referred as ‘‘total extract’’ and contained ;2.5
mg protein in 0.5 ml. It was loaded on an 18-ml Sephadex
G-200 column equilibrated with buffer A. The column
was developed with the same buffer and a total of 60
fractions of 0.25 ml each were collected. Twenty micro-
liter of each fraction was used in an immunoblot (West-
ern blot) to identify the actin-containing fractions, por-
tions of which were subsequently used in RSV transcrip-
tion reactions.
Purification of actin by antibody-affinity
chromatography
About 200 mg of anti-actin antibody (Boehringer-Mann-
heim) was coupled to 0.2 ml CNBr-activated Sepharose
by standard procedures (Harlow and Lane, 1988). The
antibody-coupled sepharose was poured into a column
and washed with 20 volumes of buffer B. HEp-2 cell total
extract (S120: see above) was dialyzed against buffer B
[10 mM Tris–HCl (pH 7.5), 10 mM NaCl, 5% glycerol] for
3 h in cold to remove the b-mercaptoethanol and then
subjected to affinity chromatography as described below.
The actin-containing sample (;100 mg protein) was ap-
plied to the column at a flow-rate of 1 drop (30 ml) per
30 s, followed by washing with 15 volumes of buffer B
containing 1% Tween 20 and 5 volumes of buffer B, and
finally elution with 0.1 M glycine, pH 2.5. The eluted
fractions were directly collected in 0.5 M Tris–HCl (pH
8.0) and used in transcription reactions without any fur-
ther treatment. Portions of the fractions were also sub-
jected to SDS–PAGE and quantitative immunoblot anal-
ysis to estimate their actin content.
146 BURKE ET AL.
Treatment of the nonactin fraction
The material that did not bind to the anti-actin affinity
column (see above), henceforth referred as ‘‘nonactin
fraction,’’ was first dialyzed against buffer B. Ten micro-
grams of this nonactin fraction was then incubated with
one of the following at 32°C for 20 min in a reaction
volume of 20 ml: (a) 100 ng of trypsin (Boehringer-Mann-
heim); (b) 50 ng of micrococcal nuclease (Boehringer-
Mannheim), and 0.5 mM CaCl2; (c) 50 ng lambda phos-
phatase and 1 mM MnCl2; or (d) 1 mM NEM (Sigma). At
the end of the incubation period, the following reagents
were added to terminate the respective reactions: (a) 1
mg of TLCK; (b) 4 mM EGTA; and (c) 50 mM sodium
vanadate and 2 min later, 0.5 mg chicken anti-lambda
phosphatase antibody; or (d) 5 mM DTT. The mixtures
were then incubated in ice for another 10 min. A portion
of the treated material (equivalent to 3 mg protein) was
used in reconstituted RSV transcription reactions.
Recombinant actin
Chicken b-actin gene cloned in pET-3d was kindly
obtained from the laboratory of Nicholas Cowan (Gao et
al., 1992). Escherichia coli BL21(DE3) cells, transformed
with this plasmid clone, were grown, induced with IPTG,
and lysed essentially as described earlier (Mazumder et
al., 1994). The insoluble fraction was dissolved in 6 M
guanidine-HCl (Gao et al., 1992) and subjected to gel
filtration chromatography using Sephadex G-200 equili-
brated with 6 M guanidine-HCl in 50 mM Tris–HCl, pH
7.0. The actin-rich fractions were identified by SDS–PAGE
and immunoblot analysis, and pooled together. Portions
of the pooled actin, containing ;1 mg actin per ml, were
then used directly in 20 ml RSV transcription reactions in
vitro.
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